Charles A. Rowland Jr serves as Executive at ENDO PHARMACEUTICALS HOLDINGS INC, where they oversee executive responsibilities. Since joining the company, Charles A. Rowland Jr has executed 76 insider transactions totaling $12.3M, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 2, 2026 involved receiving (via award) 20,400 shares valued at $0.
Charles A. Rowland Jr currently holds 20,400 shares of ENDO PHARMACEUTICALS HOLDINGS INC (ENDP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Charles A. Rowland Jr has been a net seller of ENDP stock. They have purchased $2.4M and sold $9.8M worth of shares.
Charles A. Rowland Jr's most recent insider trade was on Jan 2, 2026, when they sold 20,400 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Oct 27, 2025 | VKTX | $71.7K | Award | 16,000 | $4.48 | Discretionary |
| Oct 27, 2025 | VKTX | $127.6K | Award | 22,000 | $5.80 | Discretionary |
| Oct 27, 2025 | VKTX | $107.4K | Award | 22,000 | $4.88 | Discretionary |
| Oct 27, 2025 | VKTX | $2.1M | Sale | 60,000 | $35.57 | Discretionary |
| Jan 24, 2024 | ORTX | $0 | Disposition | 12,294 | $N/A | Discretionary |
| Dec 4, 2023 | GBIO | $225.0K | Purchase | 150,000 | $1.50 | Discretionary |
| Dec 1, 2023 | GBIO | $252.8K | Purchase | 192,960 | $1.31 | Discretionary |
| May 16, 2023 | VKTX | $1.0M | Sale | 40,000 | $25.00 | Discretionary |
| May 16, 2023 | VKTX | $43.2K | Option Exercise | 40,000 | $1.08 | Discretionary |
| Sep 19, 2022 | GBIO | $82.8K | Purchase | 15,750 | $5.26 | Discretionary |
| Sep 16, 2022 | GBIO | $183.5K | Purchase | 33,481 | $5.48 | Discretionary |
| Sep 15, 2022 | GBIO | $92.8K | Purchase | 17,147 | $5.41 | Discretionary |
| Sep 14, 2022 | GBIO | $29.7K | Purchase | 5,600 | $5.30 | Discretionary |
| Sep 13, 2022 | GBIO | $97.7K | Purchase | 18,784 | $5.20 | Discretionary |
| Aug 1, 2022 | NBRV | $1.5K | Sale | 8,496 | $0.18 | Discretionary |
| Aug 2, 2021 | NBRV | $932 | Sale | 777 | $1.20 | Discretionary |
| Jul 28, 2021 | NBRV | $0 | Award | 17,500 | $N/A | Discretionary |
| Jun 2, 2021 | BPMC | $0 | Award | 2,250 | $N/A | Discretionary |
| Jan 11, 2021 | GBIO | $500.0K | Purchase | 20,408 | $24.50 | Discretionary |
| Dec 17, 2020 | BPMC | $213.1K | Option Exercise | 10,909 | $19.53 | Discretionary |
| Dec 17, 2020 | BPMC | $1.3M | Sale | 10,909 | $117.82 | Discretionary |
| Nov 3, 2020 | BPMC | $52.2K | Option Exercise | 5,522 | $9.46 | Discretionary |
| Nov 3, 2020 | BPMC | $10.0K | Sale | 100 | $100.48 | Discretionary |
| Nov 3, 2020 | BPMC | $66.6K | Sale | 694 | $95.97 | Discretionary |
| Nov 3, 2020 | BPMC | $468.5K | Sale | 4,728 | $99.10 | Discretionary |
| Nov 2, 2020 | BPMC | $42.4K | Option Exercise | 4,478 | $9.46 | Discretionary |
| Nov 2, 2020 | BPMC | $443.8K | Sale | 4,478 | $99.11 | Discretionary |
| Jul 29, 2020 | NBRV | $0 | Award | 17,500 | $N/A | Discretionary |